Search

Simple Summary: This study analyzes the risk and prognostic factors, treatment modality and outcome of dogs with gastric dilatation-volvulus (GDV) syndrome that were encountered in a single veterinary teaching hospital. Information about patient anamnesis, treatment and follow up were collected from the management software and clinical charts. The main findings range from the prevalence of the syndrome in different breeds to surgical techniques, perioperative complications and survival. While the results about age, weight, preexisting pathologies and mortality are comparable with those of previous studies, the findings about prognostic factors, such as lactate concentration and splenectomy are not aligned. Moreover, a shift in the surgical techniques and in the medical protocols during the years was noted. Gastric dilatation-volvulus (GDV) syndrome is a life-threatening emergency and its physiopathology and treatment have been studied for decades. Despite ongoing research, the mortality rate is still high. The aims of this study are to describe the treatment and outcome of GDV patients treated from 2011 to 2024 at the veterinary teaching hospital of Grugliasco (Turin, Italy); to analyze risk and prognostic factors, comparing the obtained data with current literature; and to evaluate how patients' management has changed over the years. The study included 130 dogs with a confirmed GDV diagnosis that underwent surgery. The data were extracted from the digital and hardcopy clinical record, combined with the imaging diagnostic software and an interview submitted to the dogs' owners. The analysis showed the predominance (25.38%) of German Shepherd dogs, as well as of males (59.25%); among the latter, intact dogs were most represented (53.1%). Age between 5–10 years was most frequent in the examined population (54.69%). The surgical technique went through changes during the examined period: the belt loop has been abandoned in favor of the incisional gastropexy. The survival rate of GDV surgically treated dogs was 86.4%. Lactate blood concentration and splenectomy were not assessed as relevant prognostic factors. [ABSTRACT FROM AUTHOR]

ABSTRACT Nodal metastasis is a negative prognostic factor in dogs with mast cell tumours (MCTs), thus early detection enables more informed decision‐making and provides valuable prognostic information. The aim of this study is to assess the concordance between histopathologic findings of LNs and cytology and flow cytometry (FC), respectively, and to evaluate the ability of FC to differentiate between metastatic (HN2–HN3) and non‐metastatic (HN0–HN1) LNs. Overall, 117 LNs from 64 dogs with first occurring MCTs were submitted for cytology, histology and FC. LNs were cytologically and histologically classified according to Krick and Weishaar systems, respectively. Using FC, mast cells (MCs) were identified as IgE+ CD117+ CD5− CD21− cells and quantified as a percentage. When compared with histologic classification, cytology showed an accuracy of 88.2% in distinguishing between metastatic and non‐metastatic LNs but did not detect 25.3% of metastatic cases. FC revealed an increase in the median percentages of MCs across histologic classes, progressing from HN0 to HN3. ROC curves pinpointed 0.3% as the optimal cut‐off for distinguishing between metastatic and non‐metastatic LNs, with an accuracy of 84.3%. A 1.1% cut‐off proved valuable in identifying HN3 LNs. The combined interpretation of cytology and FC increased accuracy to 92.2%. An algorithm for guiding the combined interpretation of cytology and FC is suggested based on these findings. In conclusion, FC proves beneficial in enhancing the early detection of metastatic LNs, particularly when utilised alongside cytology. Histopathology remains essential for confirmation, enabling the discrimination of HN classes or, in doubtful cases, for the detection or exclusion of nodal metastases. [ABSTRACT FROM AUTHOR]